The economic cost of epilepsy: A review of the literature

Epilepsia

Volumn 43, Issue SUPPL. 4, 2002, Pages 3-9

  Begley Charles, E ^a   Beghi, Ettore ^b,c  

^a UNIVERSITY OF TEXAS   (United States)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

Author keywords

Cost of epilepsy; Findings; Methods

Indexed keywords

COST OF ILLNESS; EPILEPSY; EVIDENCE BASED MEDICINE; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH SERVICE; HUMAN; MEDICAL RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; STAGING;

EID: 0036282946     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.43.s.4.2.x     Document Type: Review

References (29)

1. Methodological issues in estimating the cost of epilepsy
2. Ensuring appropriate care in epilepsy: An overview of epidemiological and cost of illness considerations
3. Cost of treating patients
4. The economic cost of epilepsy
5. Cost of illness methodology: A guide to current practices and procedures
6. Guidelines for epidemiologic studies on epilepsy
7. The cost of epilepsy in the United States: An estimate from population-based and survey data
8. Prognosis of epilepsy: A review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study
9. Remission of seizures and relapse in patients with epilepsy
10. Costs of epilepsy in the United States: A model based on incidence and prognosis
11. An economic appraisal of carbamazepine, lamotrigine, phenytoin and valproate as initial treatment in adults with newly diagnosed epilepsy
12. The economic effects of introducing vigabatrin, a new antiepileptic medication
13. The effects of a disability on labor market performance: The case of epilepsy
14. Mortality in epilepsy
15. The friction cost method for measuring indirect costs of disease
16. Costs of epilepsy in an intermediate care facility for persons with mental retardation
17. Quantifying the costs of serious adverse drug reactions to antiepileptic drugs
18. A cost minimization study comparing vigabatrin, lamotrigine and gabapentin for the treatment of intractable partial epilepsy
19. Cost-effectiveness model of adjunctive lamotrigine for the treatment of epilepsy
20. Payer costs of patients diagnosed with epilepsy
21. Geographic variation in the treatment of acute myocardial infarction: The Cooperative Cardiovascular Project
22. Explaining variations in hospital death rates: Randomness, severity of illness, quality of care
23. A prospective cost-of-illness study in referral patients with disease of different severity
24. The costs of childhood epilepsy in Italy: Comparative findings from three health care settings
25. The cost of epilepsy in the United Kingdom: An estimation based on the results of two population-based studies
26. Uptake and costs of care for epilepsy: Findings from a U.K. regional study
27. Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany, and United Kingdom
28. The contributng factors to medical cost of epilepsy: An estimation based on a French prospective cohort study of patients with newly diagosed epileptic seizures (the CAROLE study)
29. Comparing the cost of epilepsy across eight European countries